Universität zu Köln

Wehling, Cyrill, Amon, Oliver, Bommer, Martin, Hoppe, Bernd, Kentouche, Karim, Schalk, Gesa, Weimer, Rolf, Wiesener, Michael, Tonshoff, Burkhard and Kirschfink, Michael (2014). Complement activation biomarkers under Eculizumab treatment in patients with atypical hemolytic-uremic syndrome (aHUS), membrano-proliferative glomerulonephritis (MPGN) and antibody-mediated renal graft rejection (AMR). Mol. Immunol., 61 (2). S. 259 - 260. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0161-5890

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Wehling, Cyrill UNSPECIFIED UNSPECIFIED UNSPECIFIED Amon, Oliver UNSPECIFIED UNSPECIFIED UNSPECIFIED Bommer, Martin UNSPECIFIED UNSPECIFIED UNSPECIFIED Hoppe, Bernd UNSPECIFIED UNSPECIFIED UNSPECIFIED Kentouche, Karim UNSPECIFIED UNSPECIFIED UNSPECIFIED Schalk, Gesa UNSPECIFIED UNSPECIFIED UNSPECIFIED Weimer, Rolf UNSPECIFIED UNSPECIFIED UNSPECIFIED Wiesener, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED Tonshoff, Burkhard UNSPECIFIED UNSPECIFIED UNSPECIFIED Kirschfink, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-427651
Journal or Publication Title:	Mol. Immunol.
Volume:	61
Number:	2
Page Range:	S. 259 - 260
Date:	2014
Publisher:	PERGAMON-ELSEVIER SCIENCE LTD
Place of Publication:	OXFORD
ISSN:	0161-5890
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language Biochemistry & Molecular Biology; Immunology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/42765